nodes	percent_of_prediction	percent_of_DWPC	metapath
Enzalutamide—Cytochrome P450 2C19 Inducers—Ritonavir—acquired immunodeficiency syndrome	0.284	0.533	CiPCiCtD
Enzalutamide—Cytochrome P450 3A4 Inducers—Amprenavir—acquired immunodeficiency syndrome	0.249	0.467	CiPCiCtD
Enzalutamide—ALB—acquired immunodeficiency syndrome	0.104	1	CbGaD
Enzalutamide—CYP2B6—Efavirenz—acquired immunodeficiency syndrome	0.00958	0.0325	CbGbCtD
Enzalutamide—CYP2B6—Nevirapine—acquired immunodeficiency syndrome	0.009	0.0305	CbGbCtD
Enzalutamide—CYP2B6—Lopinavir—acquired immunodeficiency syndrome	0.009	0.0305	CbGbCtD
Enzalutamide—CYP2B6—Amprenavir—acquired immunodeficiency syndrome	0.00814	0.0276	CbGbCtD
Enzalutamide—CYP3A5—Nevirapine—acquired immunodeficiency syndrome	0.00709	0.0241	CbGbCtD
Enzalutamide—CYP2B6—Nelfinavir—acquired immunodeficiency syndrome	0.00682	0.0231	CbGbCtD
Enzalutamide—CYP3A5—Amprenavir—acquired immunodeficiency syndrome	0.00641	0.0218	CbGbCtD
Enzalutamide—CYP3A5—Delavirdine—acquired immunodeficiency syndrome	0.00641	0.0218	CbGbCtD
Enzalutamide—CYP2B6—Ritonavir—acquired immunodeficiency syndrome	0.00617	0.0209	CbGbCtD
Enzalutamide—CYP2C8—Amprenavir—acquired immunodeficiency syndrome	0.00617	0.0209	CbGbCtD
Enzalutamide—CYP2C8—Delavirdine—acquired immunodeficiency syndrome	0.00617	0.0209	CbGbCtD
Enzalutamide—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.00609	0.0206	CbGbCtD
Enzalutamide—ALB—Saquinavir—acquired immunodeficiency syndrome	0.00605	0.0205	CbGbCtD
Enzalutamide—ALB—Zidovudine—acquired immunodeficiency syndrome	0.0058	0.0197	CbGbCtD
Enzalutamide—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.00572	0.0194	CbGbCtD
Enzalutamide—CYP3A5—Indinavir—acquired immunodeficiency syndrome	0.00554	0.0188	CbGbCtD
Enzalutamide—CYP3A5—Nelfinavir—acquired immunodeficiency syndrome	0.00538	0.0182	CbGbCtD
Enzalutamide—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.00517	0.0176	CbGbCtD
Enzalutamide—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.00517	0.0176	CbGbCtD
Enzalutamide—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.00506	0.0172	CbGbCtD
Enzalutamide—CYP3A5—Ritonavir—acquired immunodeficiency syndrome	0.00486	0.0165	CbGbCtD
Enzalutamide—CYP3A5—Saquinavir—acquired immunodeficiency syndrome	0.00486	0.0165	CbGbCtD
Enzalutamide—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.00476	0.0161	CbGbCtD
Enzalutamide—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.00476	0.0161	CbGbCtD
Enzalutamide—CYP2C8—Saquinavir—acquired immunodeficiency syndrome	0.00467	0.0159	CbGbCtD
Enzalutamide—CYP2C8—Ritonavir—acquired immunodeficiency syndrome	0.00467	0.0159	CbGbCtD
Enzalutamide—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.00463	0.0157	CbGbCtD
Enzalutamide—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.00462	0.0157	CbGbCtD
Enzalutamide—CYP2C8—Zidovudine—acquired immunodeficiency syndrome	0.00448	0.0152	CbGbCtD
Enzalutamide—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.00447	0.0152	CbGbCtD
Enzalutamide—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.00435	0.0148	CbGbCtD
Enzalutamide—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.00435	0.0148	CbGbCtD
Enzalutamide—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.00434	0.0147	CbGbCtD
Enzalutamide—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.0043	0.0146	CbGbCtD
Enzalutamide—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.0043	0.0146	CbGbCtD
Enzalutamide—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.00417	0.0142	CbGbCtD
Enzalutamide—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.00393	0.0133	CbGbCtD
Enzalutamide—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.00393	0.0133	CbGbCtD
Enzalutamide—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.00392	0.0133	CbGbCtD
Enzalutamide—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.00392	0.0133	CbGbCtD
Enzalutamide—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.00376	0.0128	CbGbCtD
Enzalutamide—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.00371	0.0126	CbGbCtD
Enzalutamide—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.0036	0.0122	CbGbCtD
Enzalutamide—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.0036	0.0122	CbGbCtD
Enzalutamide—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.0035	0.0119	CbGbCtD
Enzalutamide—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.0034	0.0115	CbGbCtD
Enzalutamide—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.0033	0.0112	CbGbCtD
Enzalutamide—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.00326	0.0111	CbGbCtD
Enzalutamide—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.00326	0.0111	CbGbCtD
Enzalutamide—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.00316	0.0107	CbGbCtD
Enzalutamide—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.00316	0.0107	CbGbCtD
Enzalutamide—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.00313	0.0106	CbGbCtD
Enzalutamide—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.00303	0.0103	CbGbCtD
Enzalutamide—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.00298	0.0101	CbGbCtD
Enzalutamide—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.00298	0.0101	CbGbCtD
Enzalutamide—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.00294	0.00998	CbGbCtD
Enzalutamide—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.00277	0.00938	CbGbCtD
Enzalutamide—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.00277	0.00938	CbGbCtD
Enzalutamide—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0025	0.00849	CbGbCtD
Enzalutamide—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0025	0.00849	CbGbCtD
Enzalutamide—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.00235	0.00796	CbGbCtD
Enzalutamide—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00216	0.00732	CbGbCtD
Enzalutamide—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0021	0.00711	CbGbCtD
Enzalutamide—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.0019	0.00643	CbGbCtD
Enzalutamide—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.0019	0.00643	CbGbCtD
Enzalutamide—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00182	0.00617	CbGbCtD
Enzalutamide—AR—semen—acquired immunodeficiency syndrome	0.00138	0.13	CbGeAlD
Enzalutamide—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.000466	0.044	CbGeAlD
Enzalutamide—CYP2C8—blood plasma—acquired immunodeficiency syndrome	0.000406	0.0384	CbGeAlD
Enzalutamide—CYP3A5—blood plasma—acquired immunodeficiency syndrome	0.000367	0.0347	CbGeAlD
Enzalutamide—CYP2B6—blood plasma—acquired immunodeficiency syndrome	0.000365	0.0345	CbGeAlD
Enzalutamide—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.000361	0.0341	CbGeAlD
Enzalutamide—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000275	0.026	CbGeAlD
Enzalutamide—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000271	0.0256	CbGeAlD
Enzalutamide—AR—skin of body—acquired immunodeficiency syndrome	0.000242	0.0228	CbGeAlD
Enzalutamide—AR—lymphoid tissue—acquired immunodeficiency syndrome	0.000196	0.0185	CbGeAlD
Enzalutamide—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.000195	0.0184	CbGeAlD
Enzalutamide—AR—digestive system—acquired immunodeficiency syndrome	0.000193	0.0183	CbGeAlD
Enzalutamide—AR—blood—acquired immunodeficiency syndrome	0.000184	0.0174	CbGeAlD
Enzalutamide—CYP2C19—digestive system—acquired immunodeficiency syndrome	0.000179	0.0169	CbGeAlD
Enzalutamide—AR—spinal cord—acquired immunodeficiency syndrome	0.000177	0.0168	CbGeAlD
Enzalutamide—CYP2B6—skin of body—acquired immunodeficiency syndrome	0.000175	0.0166	CbGeAlD
Enzalutamide—AR—vagina—acquired immunodeficiency syndrome	0.000171	0.0161	CbGeAlD
Enzalutamide—CYP2C19—blood—acquired immunodeficiency syndrome	0.000171	0.0161	CbGeAlD
Enzalutamide—AR—lung—acquired immunodeficiency syndrome	0.000161	0.0153	CbGeAlD
Enzalutamide—CYP2C19—vagina—acquired immunodeficiency syndrome	0.000158	0.015	CbGeAlD
Enzalutamide—AR—nervous system—acquired immunodeficiency syndrome	0.000149	0.0141	CbGeAlD
Enzalutamide—CYP2C8—blood—acquired immunodeficiency syndrome	0.000149	0.0141	CbGeAlD
Enzalutamide—Urethral disorder—Efavirenz—acquired immunodeficiency syndrome	0.000148	0.00263	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Didanosine—acquired immunodeficiency syndrome	0.000148	0.00262	CcSEcCtD
Enzalutamide—Bronchitis—Lamivudine—acquired immunodeficiency syndrome	0.000148	0.00262	CcSEcCtD
Enzalutamide—Arthralgia—Nelfinavir—acquired immunodeficiency syndrome	0.000147	0.00261	CcSEcCtD
Enzalutamide—Convulsion—Abacavir—acquired immunodeficiency syndrome	0.000147	0.00261	CcSEcCtD
Enzalutamide—Arthralgia—Stavudine—acquired immunodeficiency syndrome	0.000147	0.0026	CcSEcCtD
Enzalutamide—Anxiety—Nelfinavir—acquired immunodeficiency syndrome	0.000147	0.0026	CcSEcCtD
Enzalutamide—Anxiety—Stavudine—acquired immunodeficiency syndrome	0.000146	0.00259	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Nelfinavir—acquired immunodeficiency syndrome	0.000146	0.00259	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Stavudine—acquired immunodeficiency syndrome	0.000146	0.00258	CcSEcCtD
Enzalutamide—Paraesthesia—Didanosine—acquired immunodeficiency syndrome	0.000146	0.00258	CcSEcCtD
Enzalutamide—Rhinitis—Delavirdine—acquired immunodeficiency syndrome	0.000145	0.00257	CcSEcCtD
Enzalutamide—Back pain—Zidovudine—acquired immunodeficiency syndrome	0.000145	0.00257	CcSEcCtD
Enzalutamide—Arthralgia—Abacavir—acquired immunodeficiency syndrome	0.000145	0.00256	CcSEcCtD
Enzalutamide—Pneumonia—Saquinavir—acquired immunodeficiency syndrome	0.000144	0.00256	CcSEcCtD
Enzalutamide—Anxiety—Abacavir—acquired immunodeficiency syndrome	0.000144	0.00255	CcSEcCtD
Enzalutamide—Hypoaesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000144	0.00255	CcSEcCtD
Enzalutamide—AR—central nervous system—acquired immunodeficiency syndrome	0.000144	0.0136	CbGeAlD
Enzalutamide—Pharyngitis—Delavirdine—acquired immunodeficiency syndrome	0.000144	0.00254	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Abacavir—acquired immunodeficiency syndrome	0.000144	0.00254	CcSEcCtD
Enzalutamide—Neutropenia—Lamivudine—acquired immunodeficiency syndrome	0.000144	0.00254	CcSEcCtD
Enzalutamide—Infestation NOS—Saquinavir—acquired immunodeficiency syndrome	0.000144	0.00254	CcSEcCtD
Enzalutamide—Infestation—Saquinavir—acquired immunodeficiency syndrome	0.000144	0.00254	CcSEcCtD
Enzalutamide—Nervous system disorder—Nevirapine—acquired immunodeficiency syndrome	0.000143	0.00253	CcSEcCtD
Enzalutamide—Thrombocytopenia—Nevirapine—acquired immunodeficiency syndrome	0.000143	0.00253	CcSEcCtD
Enzalutamide—Oedema peripheral—Delavirdine—acquired immunodeficiency syndrome	0.000143	0.00253	CcSEcCtD
Enzalutamide—Haematuria—Ritonavir—acquired immunodeficiency syndrome	0.000142	0.00252	CcSEcCtD
Enzalutamide—Pollakiuria—Lamivudine—acquired immunodeficiency syndrome	0.000142	0.00251	CcSEcCtD
Enzalutamide—CYP2B6—lymphoid tissue—acquired immunodeficiency syndrome	0.000142	0.0134	CbGeAlD
Enzalutamide—Skin disorder—Nevirapine—acquired immunodeficiency syndrome	0.000142	0.00251	CcSEcCtD
Enzalutamide—CYP3A5—digestive system—acquired immunodeficiency syndrome	0.000141	0.0133	CbGeAlD
Enzalutamide—Epistaxis—Ritonavir—acquired immunodeficiency syndrome	0.000141	0.00249	CcSEcCtD
Enzalutamide—CYP2B6—digestive system—acquired immunodeficiency syndrome	0.00014	0.0133	CbGeAlD
Enzalutamide—Sinusitis—Ritonavir—acquired immunodeficiency syndrome	0.00014	0.00248	CcSEcCtD
Enzalutamide—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000139	0.0131	CbGeAlD
Enzalutamide—Thrombocytopenia—Nelfinavir—acquired immunodeficiency syndrome	0.000138	0.00245	CcSEcCtD
Enzalutamide—Nervous system disorder—Stavudine—acquired immunodeficiency syndrome	0.000138	0.00244	CcSEcCtD
Enzalutamide—CYP2C8—vagina—acquired immunodeficiency syndrome	0.000138	0.0131	CbGeAlD
Enzalutamide—Thrombocytopenia—Stavudine—acquired immunodeficiency syndrome	0.000138	0.00244	CcSEcCtD
Enzalutamide—Infection—Abacavir—acquired immunodeficiency syndrome	0.000138	0.00244	CcSEcCtD
Enzalutamide—Angiopathy—Efavirenz—acquired immunodeficiency syndrome	0.000137	0.00243	CcSEcCtD
Enzalutamide—Skin disorder—Nelfinavir—acquired immunodeficiency syndrome	0.000137	0.00243	CcSEcCtD
Enzalutamide—Skin disorder—Stavudine—acquired immunodeficiency syndrome	0.000137	0.00242	CcSEcCtD
Enzalutamide—Nervous system disorder—Abacavir—acquired immunodeficiency syndrome	0.000136	0.00241	CcSEcCtD
Enzalutamide—Thrombocytopenia—Abacavir—acquired immunodeficiency syndrome	0.000136	0.0024	CcSEcCtD
Enzalutamide—Epistaxis—Saquinavir—acquired immunodeficiency syndrome	0.000136	0.0024	CcSEcCtD
Enzalutamide—Back pain—Indinavir—acquired immunodeficiency syndrome	0.000135	0.00239	CcSEcCtD
Enzalutamide—Skin disorder—Abacavir—acquired immunodeficiency syndrome	0.000135	0.00239	CcSEcCtD
Enzalutamide—Vertigo—Zidovudine—acquired immunodeficiency syndrome	0.000135	0.00238	CcSEcCtD
Enzalutamide—Sinusitis—Saquinavir—acquired immunodeficiency syndrome	0.000135	0.00238	CcSEcCtD
Enzalutamide—CYP3A5—blood—acquired immunodeficiency syndrome	0.000134	0.0127	CbGeAlD
Enzalutamide—Rhinitis—Ritonavir—acquired immunodeficiency syndrome	0.000134	0.00238	CcSEcCtD
Enzalutamide—Leukopenia—Zidovudine—acquired immunodeficiency syndrome	0.000134	0.00238	CcSEcCtD
Enzalutamide—CYP2B6—blood—acquired immunodeficiency syndrome	0.000134	0.0126	CbGeAlD
Enzalutamide—Hypoaesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000133	0.00236	CcSEcCtD
Enzalutamide—Pharyngitis—Ritonavir—acquired immunodeficiency syndrome	0.000133	0.00235	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Nevirapine—acquired immunodeficiency syndrome	0.000133	0.00235	CcSEcCtD
Enzalutamide—Urinary tract disorder—Ritonavir—acquired immunodeficiency syndrome	0.000132	0.00234	CcSEcCtD
Enzalutamide—CYP2C9—blood—acquired immunodeficiency syndrome	0.000132	0.0125	CbGeAlD
Enzalutamide—Oedema peripheral—Ritonavir—acquired immunodeficiency syndrome	0.000132	0.00234	CcSEcCtD
Enzalutamide—Connective tissue disorder—Ritonavir—acquired immunodeficiency syndrome	0.000132	0.00233	CcSEcCtD
Enzalutamide—ALB—brain—acquired immunodeficiency syndrome	0.000131	0.0124	CbGeAlD
Enzalutamide—Urethral disorder—Ritonavir—acquired immunodeficiency syndrome	0.000131	0.00232	CcSEcCtD
Enzalutamide—Paraesthesia—Nevirapine—acquired immunodeficiency syndrome	0.000131	0.00232	CcSEcCtD
Enzalutamide—Convulsion—Zidovudine—acquired immunodeficiency syndrome	0.00013	0.0023	CcSEcCtD
Enzalutamide—Rhinitis—Saquinavir—acquired immunodeficiency syndrome	0.000129	0.00229	CcSEcCtD
Enzalutamide—Epistaxis—Lamivudine—acquired immunodeficiency syndrome	0.000129	0.00229	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Nelfinavir—acquired immunodeficiency syndrome	0.000129	0.00228	CcSEcCtD
Enzalutamide—Sinusitis—Lamivudine—acquired immunodeficiency syndrome	0.000129	0.00227	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Stavudine—acquired immunodeficiency syndrome	0.000128	0.00227	CcSEcCtD
Enzalutamide—Hypoaesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000128	0.00227	CcSEcCtD
Enzalutamide—Pharyngitis—Saquinavir—acquired immunodeficiency syndrome	0.000128	0.00226	CcSEcCtD
Enzalutamide—Insomnia—Nelfinavir—acquired immunodeficiency syndrome	0.000128	0.00226	CcSEcCtD
Enzalutamide—Arthralgia—Zidovudine—acquired immunodeficiency syndrome	0.000128	0.00226	CcSEcCtD
Enzalutamide—Asthenia—Amprenavir—acquired immunodeficiency syndrome	0.000128	0.00226	CcSEcCtD
Enzalutamide—Back pain—Efavirenz—acquired immunodeficiency syndrome	0.000128	0.00226	CcSEcCtD
Enzalutamide—Insomnia—Stavudine—acquired immunodeficiency syndrome	0.000127	0.00225	CcSEcCtD
Enzalutamide—Urinary tract disorder—Saquinavir—acquired immunodeficiency syndrome	0.000127	0.00225	CcSEcCtD
Enzalutamide—Anxiety—Zidovudine—acquired immunodeficiency syndrome	0.000127	0.00225	CcSEcCtD
Enzalutamide—ALB—lymph node—acquired immunodeficiency syndrome	0.000127	0.012	CbGeAlD
Enzalutamide—Paraesthesia—Nelfinavir—acquired immunodeficiency syndrome	0.000127	0.00225	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Zidovudine—acquired immunodeficiency syndrome	0.000127	0.00224	CcSEcCtD
Enzalutamide—Connective tissue disorder—Saquinavir—acquired immunodeficiency syndrome	0.000127	0.00224	CcSEcCtD
Enzalutamide—Paraesthesia—Stavudine—acquired immunodeficiency syndrome	0.000127	0.00224	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Abacavir—acquired immunodeficiency syndrome	0.000126	0.00224	CcSEcCtD
Enzalutamide—Urethral disorder—Saquinavir—acquired immunodeficiency syndrome	0.000126	0.00224	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Nevirapine—acquired immunodeficiency syndrome	0.000126	0.00223	CcSEcCtD
Enzalutamide—Pruritus—Amprenavir—acquired immunodeficiency syndrome	0.000126	0.00223	CcSEcCtD
Enzalutamide—Fatigue—Nevirapine—acquired immunodeficiency syndrome	0.000126	0.00223	CcSEcCtD
Enzalutamide—Insomnia—Abacavir—acquired immunodeficiency syndrome	0.000126	0.00222	CcSEcCtD
Enzalutamide—Vertigo—Indinavir—acquired immunodeficiency syndrome	0.000125	0.00222	CcSEcCtD
Enzalutamide—Paraesthesia—Abacavir—acquired immunodeficiency syndrome	0.000125	0.0022	CcSEcCtD
Enzalutamide—CYP3A5—vagina—acquired immunodeficiency syndrome	0.000125	0.0118	CbGeAlD
Enzalutamide—CYP2B6—vagina—acquired immunodeficiency syndrome	0.000124	0.0117	CbGeAlD
Enzalutamide—Rhinitis—Lamivudine—acquired immunodeficiency syndrome	0.000123	0.00218	CcSEcCtD
Enzalutamide—Hypoaesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000122	0.00217	CcSEcCtD
Enzalutamide—Pharyngitis—Lamivudine—acquired immunodeficiency syndrome	0.000122	0.00216	CcSEcCtD
Enzalutamide—Back pain—Delavirdine—acquired immunodeficiency syndrome	0.000122	0.00216	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Nelfinavir—acquired immunodeficiency syndrome	0.000122	0.00216	CcSEcCtD
Enzalutamide—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.000122	0.00215	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Stavudine—acquired immunodeficiency syndrome	0.000122	0.00215	CcSEcCtD
Enzalutamide—Angiopathy—Ritonavir—acquired immunodeficiency syndrome	0.000122	0.00215	CcSEcCtD
Enzalutamide—Fatigue—Stavudine—acquired immunodeficiency syndrome	0.000121	0.00215	CcSEcCtD
Enzalutamide—Connective tissue disorder—Lamivudine—acquired immunodeficiency syndrome	0.000121	0.00214	CcSEcCtD
Enzalutamide—Nervous system disorder—Zidovudine—acquired immunodeficiency syndrome	0.00012	0.00212	CcSEcCtD
Enzalutamide—Thrombocytopenia—Zidovudine—acquired immunodeficiency syndrome	0.00012	0.00212	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Abacavir—acquired immunodeficiency syndrome	0.00012	0.00212	CcSEcCtD
Enzalutamide—Fatigue—Abacavir—acquired immunodeficiency syndrome	0.00012	0.00212	CcSEcCtD
Enzalutamide—Skin disorder—Zidovudine—acquired immunodeficiency syndrome	0.000119	0.0021	CcSEcCtD
Enzalutamide—Arthralgia—Indinavir—acquired immunodeficiency syndrome	0.000119	0.0021	CcSEcCtD
Enzalutamide—Vertigo—Efavirenz—acquired immunodeficiency syndrome	0.000118	0.0021	CcSEcCtD
Enzalutamide—Anxiety—Indinavir—acquired immunodeficiency syndrome	0.000118	0.00209	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Indinavir—acquired immunodeficiency syndrome	0.000118	0.00209	CcSEcCtD
Enzalutamide—CYP3A5—lung—acquired immunodeficiency syndrome	0.000118	0.0111	CbGeAlD
Enzalutamide—Mental disorder—Ritonavir—acquired immunodeficiency syndrome	0.000117	0.00208	CcSEcCtD
Enzalutamide—CYP2B6—lung—acquired immunodeficiency syndrome	0.000117	0.0111	CbGeAlD
Enzalutamide—Angiopathy—Saquinavir—acquired immunodeficiency syndrome	0.000117	0.00207	CcSEcCtD
Enzalutamide—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.000116	0.00206	CcSEcCtD
Enzalutamide—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.000115	0.00203	CcSEcCtD
Enzalutamide—AR—brain—acquired immunodeficiency syndrome	0.000114	0.0108	CbGeAlD
Enzalutamide—Convulsion—Efavirenz—acquired immunodeficiency syndrome	0.000114	0.00202	CcSEcCtD
Enzalutamide—Hypertension—Efavirenz—acquired immunodeficiency syndrome	0.000114	0.00201	CcSEcCtD
Enzalutamide—Vertigo—Delavirdine—acquired immunodeficiency syndrome	0.000113	0.00201	CcSEcCtD
Enzalutamide—Mental disorder—Saquinavir—acquired immunodeficiency syndrome	0.000113	0.002	CcSEcCtD
Enzalutamide—Leukopenia—Delavirdine—acquired immunodeficiency syndrome	0.000113	0.002	CcSEcCtD
Enzalutamide—Back pain—Ritonavir—acquired immunodeficiency syndrome	0.000113	0.002	CcSEcCtD
Enzalutamide—Arthralgia—Efavirenz—acquired immunodeficiency syndrome	0.000112	0.00199	CcSEcCtD
Enzalutamide—Anxiety—Efavirenz—acquired immunodeficiency syndrome	0.000112	0.00198	CcSEcCtD
Enzalutamide—Nervous system disorder—Indinavir—acquired immunodeficiency syndrome	0.000112	0.00198	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Zidovudine—acquired immunodeficiency syndrome	0.000112	0.00197	CcSEcCtD
Enzalutamide—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000112	0.00197	CcSEcCtD
Enzalutamide—Thrombocytopenia—Indinavir—acquired immunodeficiency syndrome	0.000111	0.00197	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Efavirenz—acquired immunodeficiency syndrome	0.000111	0.00197	CcSEcCtD
Enzalutamide—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.000111	0.00196	CcSEcCtD
Enzalutamide—Insomnia—Zidovudine—acquired immunodeficiency syndrome	0.000111	0.00196	CcSEcCtD
Enzalutamide—Skin disorder—Indinavir—acquired immunodeficiency syndrome	0.000111	0.00196	CcSEcCtD
Enzalutamide—AR—lymph node—acquired immunodeficiency syndrome	0.00011	0.0104	CbGeAlD
Enzalutamide—Paraesthesia—Zidovudine—acquired immunodeficiency syndrome	0.00011	0.00195	CcSEcCtD
Enzalutamide—Hypertension—Delavirdine—acquired immunodeficiency syndrome	0.000109	0.00193	CcSEcCtD
Enzalutamide—Back pain—Saquinavir—acquired immunodeficiency syndrome	0.000109	0.00192	CcSEcCtD
Enzalutamide—CYP2B6—nervous system—acquired immunodeficiency syndrome	0.000108	0.0103	CbGeAlD
Enzalutamide—Arthralgia—Delavirdine—acquired immunodeficiency syndrome	0.000107	0.0019	CcSEcCtD
Enzalutamide—Anxiety—Delavirdine—acquired immunodeficiency syndrome	0.000107	0.00189	CcSEcCtD
Enzalutamide—ABCB1—retina—acquired immunodeficiency syndrome	0.000107	0.0101	CbGeAlD
Enzalutamide—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000106	0.01	CbGeAlD
Enzalutamide—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.000106	0.00187	CcSEcCtD
Enzalutamide—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.000106	0.00187	CcSEcCtD
Enzalutamide—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.000106	0.00187	CcSEcCtD
Enzalutamide—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.000105	0.00186	CcSEcCtD
Enzalutamide—Vertigo—Ritonavir—acquired immunodeficiency syndrome	0.000105	0.00185	CcSEcCtD
Enzalutamide—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000105	0.00185	CcSEcCtD
Enzalutamide—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.000105	0.00185	CcSEcCtD
Enzalutamide—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.000104	0.00185	CcSEcCtD
Enzalutamide—CYP2B6—central nervous system—acquired immunodeficiency syndrome	0.000104	0.00987	CbGeAlD
Enzalutamide—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000104	0.00985	CbGeAlD
Enzalutamide—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.000104	0.00184	CcSEcCtD
Enzalutamide—Back pain—Lamivudine—acquired immunodeficiency syndrome	0.000104	0.00183	CcSEcCtD
Enzalutamide—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000103	0.00183	CcSEcCtD
Enzalutamide—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000103	0.00182	CcSEcCtD
Enzalutamide—Infection—Delavirdine—acquired immunodeficiency syndrome	0.000102	0.00181	CcSEcCtD
Enzalutamide—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000102	0.00181	CcSEcCtD
Enzalutamide—Headache—Didanosine—acquired immunodeficiency syndrome	0.000102	0.0018	CcSEcCtD
Enzalutamide—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000101	0.00179	CcSEcCtD
Enzalutamide—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000101	0.00179	CcSEcCtD
Enzalutamide—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000101	0.00179	CcSEcCtD
Enzalutamide—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.000101	0.00178	CcSEcCtD
Enzalutamide—CYP3A4—blood—acquired immunodeficiency syndrome	0.000101	0.00954	CbGeAlD
Enzalutamide—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000101	0.00178	CcSEcCtD
Enzalutamide—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000101	0.00178	CcSEcCtD
Enzalutamide—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.0001	0.00178	CcSEcCtD
Enzalutamide—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.0001	0.00177	CcSEcCtD
Enzalutamide—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.0001	0.00177	CcSEcCtD
Enzalutamide—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	9.98e-05	0.00177	CcSEcCtD
Enzalutamide—Pruritus—Stavudine—acquired immunodeficiency syndrome	9.97e-05	0.00176	CcSEcCtD
Enzalutamide—Asthenia—Abacavir—acquired immunodeficiency syndrome	9.96e-05	0.00176	CcSEcCtD
Enzalutamide—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	9.93e-05	0.00176	CcSEcCtD
Enzalutamide—CYP2D6—blood—acquired immunodeficiency syndrome	9.92e-05	0.00938	CbGeAlD
Enzalutamide—Anxiety—Ritonavir—acquired immunodeficiency syndrome	9.9e-05	0.00175	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	9.86e-05	0.00174	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	9.83e-05	0.00174	CcSEcCtD
Enzalutamide—Pruritus—Abacavir—acquired immunodeficiency syndrome	9.82e-05	0.00174	CcSEcCtD
Enzalutamide—Fatigue—Indinavir—acquired immunodeficiency syndrome	9.82e-05	0.00174	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	9.8e-05	0.00173	CcSEcCtD
Enzalutamide—Insomnia—Efavirenz—acquired immunodeficiency syndrome	9.73e-05	0.00172	CcSEcCtD
Enzalutamide—Convulsion—Saquinavir—acquired immunodeficiency syndrome	9.73e-05	0.00172	CcSEcCtD
Enzalutamide—Hypertension—Saquinavir—acquired immunodeficiency syndrome	9.69e-05	0.00171	CcSEcCtD
Enzalutamide—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	9.67e-05	0.00171	CcSEcCtD
Enzalutamide—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	9.66e-05	0.00171	CcSEcCtD
Enzalutamide—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	9.64e-05	0.00171	CcSEcCtD
Enzalutamide—Vertigo—Lamivudine—acquired immunodeficiency syndrome	9.62e-05	0.0017	CcSEcCtD
Enzalutamide—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	9.59e-05	0.0017	CcSEcCtD
Enzalutamide—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	9.56e-05	0.00169	CcSEcCtD
Enzalutamide—Anxiety—Saquinavir—acquired immunodeficiency syndrome	9.53e-05	0.00169	CcSEcCtD
Enzalutamide—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	9.5e-05	0.00168	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	9.49e-05	0.00168	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	9.38e-05	0.00166	CcSEcCtD
Enzalutamide—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	9.34e-05	0.00165	CcSEcCtD
Enzalutamide—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	9.34e-05	0.00165	CcSEcCtD
Enzalutamide—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	9.32e-05	0.00165	CcSEcCtD
Enzalutamide—Dizziness—Stavudine—acquired immunodeficiency syndrome	9.32e-05	0.00165	CcSEcCtD
Enzalutamide—Insomnia—Delavirdine—acquired immunodeficiency syndrome	9.31e-05	0.00165	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	9.29e-05	0.00164	CcSEcCtD
Enzalutamide—Convulsion—Lamivudine—acquired immunodeficiency syndrome	9.28e-05	0.00164	CcSEcCtD
Enzalutamide—Fatigue—Efavirenz—acquired immunodeficiency syndrome	9.28e-05	0.00164	CcSEcCtD
Enzalutamide—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	9.25e-05	0.00164	CcSEcCtD
Enzalutamide—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	9.24e-05	0.00164	CcSEcCtD
Enzalutamide—CYP2C8—brain—acquired immunodeficiency syndrome	9.24e-05	0.00874	CbGeAlD
Enzalutamide—Dizziness—Abacavir—acquired immunodeficiency syndrome	9.18e-05	0.00162	CcSEcCtD
Enzalutamide—Headache—Nevirapine—acquired immunodeficiency syndrome	9.14e-05	0.00162	CcSEcCtD
Enzalutamide—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	9.12e-05	0.00161	CcSEcCtD
Enzalutamide—Infection—Saquinavir—acquired immunodeficiency syndrome	9.1e-05	0.00161	CcSEcCtD
Enzalutamide—Anxiety—Lamivudine—acquired immunodeficiency syndrome	9.09e-05	0.00161	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	9.06e-05	0.0016	CcSEcCtD
Enzalutamide—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	8.99e-05	0.00159	CcSEcCtD
Enzalutamide—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	8.97e-05	0.00159	CcSEcCtD
Enzalutamide—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	8.9e-05	0.00157	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	8.89e-05	0.00157	CcSEcCtD
Enzalutamide—Fatigue—Delavirdine—acquired immunodeficiency syndrome	8.88e-05	0.00157	CcSEcCtD
Enzalutamide—Headache—Nelfinavir—acquired immunodeficiency syndrome	8.85e-05	0.00157	CcSEcCtD
Enzalutamide—Headache—Stavudine—acquired immunodeficiency syndrome	8.83e-05	0.00156	CcSEcCtD
Enzalutamide—Asthenia—Zidovudine—acquired immunodeficiency syndrome	8.79e-05	0.00155	CcSEcCtD
Enzalutamide—Headache—Abacavir—acquired immunodeficiency syndrome	8.69e-05	0.00154	CcSEcCtD
Enzalutamide—Infection—Lamivudine—acquired immunodeficiency syndrome	8.68e-05	0.00154	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	8.67e-05	0.00153	CcSEcCtD
Enzalutamide—Pruritus—Zidovudine—acquired immunodeficiency syndrome	8.66e-05	0.00153	CcSEcCtD
Enzalutamide—Insomnia—Ritonavir—acquired immunodeficiency syndrome	8.61e-05	0.00152	CcSEcCtD
Enzalutamide—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	8.57e-05	0.00152	CcSEcCtD
Enzalutamide—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	8.56e-05	0.00151	CcSEcCtD
Enzalutamide—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	8.55e-05	0.00151	CcSEcCtD
Enzalutamide—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	8.49e-05	0.0015	CcSEcCtD
Enzalutamide—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	8.38e-05	0.00148	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	8.35e-05	0.00148	CcSEcCtD
Enzalutamide—Insomnia—Saquinavir—acquired immunodeficiency syndrome	8.29e-05	0.00147	CcSEcCtD
Enzalutamide—CYP2B6—brain—acquired immunodeficiency syndrome	8.29e-05	0.00784	CbGeAlD
Enzalutamide—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	8.23e-05	0.00146	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	8.22e-05	0.00145	CcSEcCtD
Enzalutamide—Fatigue—Ritonavir—acquired immunodeficiency syndrome	8.21e-05	0.00145	CcSEcCtD
Enzalutamide—CYP3A4—nervous system—acquired immunodeficiency syndrome	8.19e-05	0.00774	CbGeAlD
Enzalutamide—Asthenia—Indinavir—acquired immunodeficiency syndrome	8.17e-05	0.00145	CcSEcCtD
Enzalutamide—Dizziness—Zidovudine—acquired immunodeficiency syndrome	8.1e-05	0.00143	CcSEcCtD
Enzalutamide—Pruritus—Indinavir—acquired immunodeficiency syndrome	8.06e-05	0.00143	CcSEcCtD
Enzalutamide—CYP2D6—nervous system—acquired immunodeficiency syndrome	8.06e-05	0.00762	CbGeAlD
Enzalutamide—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	7.96e-05	0.00141	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	7.91e-05	0.0014	CcSEcCtD
Enzalutamide—Insomnia—Lamivudine—acquired immunodeficiency syndrome	7.91e-05	0.0014	CcSEcCtD
Enzalutamide—Fatigue—Saquinavir—acquired immunodeficiency syndrome	7.9e-05	0.0014	CcSEcCtD
Enzalutamide—CYP3A4—central nervous system—acquired immunodeficiency syndrome	7.88e-05	0.00745	CbGeAlD
Enzalutamide—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	7.85e-05	0.00139	CcSEcCtD
Enzalutamide—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	7.79e-05	0.00138	CcSEcCtD
Enzalutamide—CYP2D6—central nervous system—acquired immunodeficiency syndrome	7.76e-05	0.00733	CbGeAlD
Enzalutamide—Asthenia—Efavirenz—acquired immunodeficiency syndrome	7.72e-05	0.00137	CcSEcCtD
Enzalutamide—Headache—Zidovudine—acquired immunodeficiency syndrome	7.67e-05	0.00136	CcSEcCtD
Enzalutamide—Pruritus—Efavirenz—acquired immunodeficiency syndrome	7.61e-05	0.00135	CcSEcCtD
Enzalutamide—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	7.59e-05	0.00717	CbGeAlD
Enzalutamide—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	7.55e-05	0.00134	CcSEcCtD
Enzalutamide—Fatigue—Lamivudine—acquired immunodeficiency syndrome	7.54e-05	0.00133	CcSEcCtD
Enzalutamide—Dizziness—Indinavir—acquired immunodeficiency syndrome	7.53e-05	0.00133	CcSEcCtD
Enzalutamide—ABCB1—digestive system—acquired immunodeficiency syndrome	7.49e-05	0.00709	CbGeAlD
Enzalutamide—Asthenia—Delavirdine—acquired immunodeficiency syndrome	7.39e-05	0.00131	CcSEcCtD
Enzalutamide—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	7.36e-05	0.0013	CcSEcCtD
Enzalutamide—Pruritus—Delavirdine—acquired immunodeficiency syndrome	7.28e-05	0.00129	CcSEcCtD
Enzalutamide—ABCB1—blood—acquired immunodeficiency syndrome	7.14e-05	0.00675	CbGeAlD
Enzalutamide—Headache—Indinavir—acquired immunodeficiency syndrome	7.13e-05	0.00126	CcSEcCtD
Enzalutamide—Dizziness—Efavirenz—acquired immunodeficiency syndrome	7.11e-05	0.00126	CcSEcCtD
Enzalutamide—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	7.04e-05	0.00125	CcSEcCtD
Enzalutamide—ABCB1—bone marrow—acquired immunodeficiency syndrome	6.91e-05	0.00653	CbGeAlD
Enzalutamide—ABCB1—spinal cord—acquired immunodeficiency syndrome	6.88e-05	0.0065	CbGeAlD
Enzalutamide—Asthenia—Ritonavir—acquired immunodeficiency syndrome	6.83e-05	0.00121	CcSEcCtD
Enzalutamide—Dizziness—Delavirdine—acquired immunodeficiency syndrome	6.81e-05	0.0012	CcSEcCtD
Enzalutamide—Headache—Efavirenz—acquired immunodeficiency syndrome	6.74e-05	0.00119	CcSEcCtD
Enzalutamide—Pruritus—Ritonavir—acquired immunodeficiency syndrome	6.74e-05	0.00119	CcSEcCtD
Enzalutamide—ABCB1—vagina—acquired immunodeficiency syndrome	6.62e-05	0.00626	CbGeAlD
Enzalutamide—Asthenia—Saquinavir—acquired immunodeficiency syndrome	6.57e-05	0.00116	CcSEcCtD
Enzalutamide—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	6.51e-05	0.00115	CcSEcCtD
Enzalutamide—Pruritus—Saquinavir—acquired immunodeficiency syndrome	6.48e-05	0.00115	CcSEcCtD
Enzalutamide—Headache—Delavirdine—acquired immunodeficiency syndrome	6.45e-05	0.00114	CcSEcCtD
Enzalutamide—Dizziness—Ritonavir—acquired immunodeficiency syndrome	6.3e-05	0.00111	CcSEcCtD
Enzalutamide—Asthenia—Lamivudine—acquired immunodeficiency syndrome	6.27e-05	0.00111	CcSEcCtD
Enzalutamide—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	6.27e-05	0.00111	CcSEcCtD
Enzalutamide—ABCB1—lung—acquired immunodeficiency syndrome	6.26e-05	0.00592	CbGeAlD
Enzalutamide—Pruritus—Lamivudine—acquired immunodeficiency syndrome	6.18e-05	0.00109	CcSEcCtD
Enzalutamide—CYP2D6—brain—acquired immunodeficiency syndrome	6.16e-05	0.00582	CbGeAlD
Enzalutamide—Dizziness—Saquinavir—acquired immunodeficiency syndrome	6.06e-05	0.00107	CcSEcCtD
Enzalutamide—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	5.98e-05	0.00106	CcSEcCtD
Enzalutamide—Headache—Ritonavir—acquired immunodeficiency syndrome	5.96e-05	0.00106	CcSEcCtD
Enzalutamide—ABCB1—nervous system—acquired immunodeficiency syndrome	5.8e-05	0.00548	CbGeAlD
Enzalutamide—Dizziness—Lamivudine—acquired immunodeficiency syndrome	5.78e-05	0.00102	CcSEcCtD
Enzalutamide—Headache—Saquinavir—acquired immunodeficiency syndrome	5.74e-05	0.00102	CcSEcCtD
Enzalutamide—ABCB1—central nervous system—acquired immunodeficiency syndrome	5.58e-05	0.00528	CbGeAlD
Enzalutamide—Headache—Lamivudine—acquired immunodeficiency syndrome	5.48e-05	0.000969	CcSEcCtD
Enzalutamide—ABCB1—brain—acquired immunodeficiency syndrome	4.43e-05	0.00419	CbGeAlD
Enzalutamide—ABCB1—lymph node—acquired immunodeficiency syndrome	4.28e-05	0.00405	CbGeAlD
